dNA BALL IMAGE
spacer

Keyword Search:

arrow_search0 Advanced Search
image_big

Featured Articles

What is next for REMS? :On September 27, 2007, the Food and Drug Administration Act of 2007 (FDAAA) was signed into law. FDAAA 2007 included several key provisions, and gav

read more... Share: E-MAIL

Molecular diagnostic testing: healthy outlook :  Reprint of an Article published by BioPhotonics    Molecular diagnostics is the fastest growing segment of the in

read more... Share: E-MAIL

See more articles

Featured Reports

  
image big  
Title : Risk Evaluation and Mitigation Strategies (REMS) Trends and Implications for BioPharma
Sector: Biopharmaceuticals
Report type: Market Report
Date: 02/02/2011
Abstract: On September 27, 2007, the Food and Drug Administration Act of 2007 (FDAAA) was signed into law. FDAAA 2007 included several key prov...read more...
Price: $ 1,400.00
View | Wishlist | Add to Cart
image big  
Title : Molecular Dx: Market Size, Segmentation, Growth and Opportunities
Sector: Diagnostics
Report type: Market Report
Date: 05/19/2011
Abstract: Molecular diagnostics (MDx) is a class of diagnostic tests that identify nucleic acids such as DNA. These nucleic acids can be geneti...read more...
Price: $ 1,800.00
View | Wishlist | Add to Cart
image big  
Title : Fluidigm Due Diligence: Company Profile, SWOT Analysis and Market Opportunity
Sector: Life_Sciences
Report type: Company Profile
Date: 03/11/2011
Abstract: Fluidigm is a life science company that develops and distributes instruments and chips for genomic analysis and X-ray crystallography...read more...
Price: $ 950.00
View | Wishlist | Add to Cart